作者: Regina Katzenschlager
DOI: 10.1007/978-1-4471-6503-3_5
关键词:
摘要: The current pharmacological treatment options for dyskinesia in Parkison’s disease are based on three principles: adjusting the ongoing treatment, adding specific antidyskinetic drugs, or administering dopaminergic drugs continuously via pump systems.